Cargando…

Genome-Wide Analysis of lncRNA-mRNA Co-Expression Networks in CD133+/CD44+ Stem-like PDAC Cells

SIMPLE SUMMARY: The prognosis of pancreatic ductal adenocarcinoma (PDAC) remains unfavorable among PDAC patients and is accompanied by high mortality rates. Cancer stem cells (CSCs) have a main role in PDAC aggressiveness. The present study sheds light on the molecular characterization of cancer ste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eptaminitaki, Giasemi C., Zaravinos, Apostolos, Stellas, Dimitris, Panagopoulou, Maria, Karaliota, Sevasti, Baltsavia, Ismini, Iliopoulos, Ioannis, Chatzaki, Ekaterini, Iliopoulos, Dimitrios, Baritaki, Stavroula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954787/ https://www.ncbi.nlm.nih.gov/pubmed/36831395 http://dx.doi.org/10.3390/cancers15041053

Ejemplares similares

Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy
por: Eptaminitaki, Giasemi C., et al.
Publicado: (2021)

Tissue-Specific Methylation Biosignatures for Monitoring Diseases: An In Silico Approach
por: Karaglani, Makrina, et al.
Publicado: (2022)

RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact
por: Zaravinos, Apostolos, et al.
Publicado: (2018)

Prediction and Ranking of Biomarkers Using multiple UniReD
por: Baltsavia, Ismini, et al.
Publicado: (2022)

Deciphering the Methylation Landscape in Breast Cancer: Diagnostic and Prognostic Biosignatures through Automated Machine Learning
por: Panagopoulou, Maria, et al.
Publicado: (2021)

Cross-Talks between RKIP and YY1 through a Multilevel Bioinformatics Pan-Cancer Analysis
por: Baritaki, Stavroula, et al.
Publicado: (2023)

Chronic Stress, Inflammation, and Colon Cancer: A CRH System-Driven Molecular Crosstalk
por: Baritaki, Stavroula, et al.
Publicado: (2019)

Methylation Status of Corticotropin-Releasing Factor (CRF) Receptor Genes in Colorectal Cancer
por: Panagopoulou, Maria, et al.
Publicado: (2021)

RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity
por: Touboul, Roni, et al.
Publicado: (2021)

The Role of RKIP in the Regulation of EMT in the Tumor Microenvironment
por: Cessna, Hannah, et al.
Publicado: (2022)

Heterodimeric IL-15 in Cancer Immunotherapy
por: Bergamaschi, Cristina, et al.
Publicado: (2021)

Current Perspectives in Cancer Immunotherapy
por: Christofi, Theodoulakis, et al.
Publicado: (2019)

Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision Medicine
por: Panagopoulou, Maria, et al.
Publicado: (2021)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC
por: Stravokefalou, Vasiliki, et al.
Publicado: (2023)

ENPP2 Methylation in Health and Cancer
por: Panagopoulou, Maria, et al.
Publicado: (2021)

Autotaxin in Breast Cancer: Role, Epigenetic Regulation and Clinical Implications
por: Drosouni, Andrianna, et al.
Publicado: (2022)

The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
por: Abdou Hassan, Wael, et al.
Publicado: (2022)

ProteoSign v2: a faster and evolved user-friendly online tool for statistical analyses of differential proteomics
por: Theodorakis, Evangelos, et al.
Publicado: (2021)

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma
por: Nosrati, Anahita, et al.
Publicado: (2014)

Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer
por: WANG, CHUNXIA, et al.
Publicado: (2012)

CGG toolkit: Software components for computational genomics
por: Vasileiou, Dimitrios, et al.
Publicado: (2023)

Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients
por: Bergamaschi, Cristina, et al.
Publicado: (2021)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Coexpression analysis of CD133 and CD44 identifies Proneural and Mesenchymal subtypes of glioblastoma multiforme
por: Brown, Daniel V., et al.
Publicado: (2015)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
por: Han, Zhengquan, et al.
Publicado: (2015)

CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure
por: Tsunekuni, Kenta, et al.
Publicado: (2019)

Methylisoindigo and Its Bromo-Derivatives Are Selective Tyrosine Kinase Inhibitors, Repressing Cellular Stat3 Activity, and Target CD133+ Cancer Stem Cells in PDAC
por: Tegethoff, Jana, et al.
Publicado: (2017)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

Prognostic value of CD133(+) CD54(+) CD44(+) circulating tumor cells in colorectal cancer with liver metastasis
por: Fang, Chao, et al.
Publicado: (2017)

MicroRNA Gene Networks in Oncogenesis
por: Drakaki, Alexandra, et al.
Publicado: (2009)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

Cobalt ferrite nanoparticle for the elimination of CD133+CD44(+) and CD44(+)CD24(−), in breast and skin cancer stem cells, using non-ionizing treatments
por: Khalili Najafabad, Bahareh, et al.
Publicado: (2023)

Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer
por: Zhou, Jin-Yong, et al.
Publicado: (2016)

Discovery of New 1,4,6-Trisubstituted-1H-pyrazolo[3,4-b]pyridines with Anti-Tumor Efficacy in Mouse Model of Breast Cancer †
por: Georgiou, Maria, et al.
Publicado: (2023)

TIMP-1 and CD82, a promising combined evaluation marker for PDAC
por: Zhang, Jiexin, et al.
Publicado: (2016)

Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature
por: Erhart, Friedrich, et al.
Publicado: (2018)

Study on the Biological Characteristics of CD133(+) Cells Interfered by RNA Interference in Gastric Cancer
por: Yu, Ji-wei, et al.
Publicado: (2014)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hifrvln2gmli6i31fupv37hf0o